erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the http://lm360.us/Leuchs-neighbour-of-Barkema-from-Toronto?Mcthaymot=148
-
.
.